N-Acetylglucosamine

N-Acetylglucosamine

SCHEMBL20339332

CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O.C[C@@H](O[C@@H]1[C@@H](N)[C@@H](O)O[C@H](CO)[C@H]1O)C(=O)O

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.79
▸ ALDH1A1 P00352 2/20 0.54
▸ THRB P10828 1/20 0.54
▸ NOD2 Q9HC29 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ ESR1 P03372 1/20 0.42
▸ PGR P06401 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ AR P10275 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ TBXA2R P21731 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HK1 P19367 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Acetylglucosamine SCHEMBL29031296 1.00 MAPK1 (0.79) MAPK1ALDH1A1THRBNOD2KDM4E
N-Acetylglucosamine SCHEMBL28342076 0.91 MAPK1 (0.95) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL6552473 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL13575286 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL14520991 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL57603 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL57604 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL15504324 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
SCHEMBL20516489 0.88 MAPK1 (1.00) MAPK1ALDH1A1THRBNOD2KDM4E
Acetic Acid SCHEMBL28209162 0.88 MAPK1 (0.65) MAPK1ALDH1A1THRBNOD2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844829-B2 Microparticles from Streptococcus pneumoniae as vaccine antigens ZALVAC AB (SE) 2023-12-19 — — US disclosed
US-20230330203-A1 MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS ZALVAC AB (SE) 2023-10-19 — — US disclosed
US-20200338189-A1 Immunogenic sequences from a Phage Tail Length Tape Measure Protein, bacteria expressing the same and their use in treating a cancer INSTITUT GUSTAVE ROUSSY (FR) 2020-10-29 — — US disclosed
EP-3562838-A2 MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS Henriques Normark, Birgitta (SE) 2019-11-06 — — EP disclosed
US-20190328861-A1 MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS BIRGITTA HENRIQUES NORMARK (SE) 2019-10-31 — — US disclosed
WO-2018124959-A2 MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS HENRIQUES NORMARK BIRGITTA (SE) 2018-07-05 — — WO disclosed
Send feedback